VREX · NASDAQ · Medical - Devices

Varex Imaging (VREX)

Builds X-ray imaging components for medical, security, cargo, and industrial systems.

$18.50
vs last close+0.03 (+0.14%)
Loading prices…

Varex Imaging CorporationVREX
Health Care

Supplies X-ray tubes, detectors, software, accelerators, and inspection systems for Medical and Industrial customers. Sales are mainly OEM-driven, with demand shaped by CT, cargo screening, photon-counting detectors, trade rules, tariffs, and product innovation.

Designs and manufactures X-ray imaging components for Medical and Industrial customers. The portfolio includes X-ray tubes, flat panel and photon-counting detectors, linear accelerators, image-processing software, and selected stand-alone inspection systems used in CT, mammography, oncology, dental, security, cargo, and industrial workflows.

Revenue is organized around Medical and Industrial segments and flows mainly through global OEMs that build Varex components into larger systems, with replacement products also sold through service firms, distributors, and direct channels. Operations span North America, Europe, Asia, and India. The business depends on OEM demand, CT and cargo-system cycles, photon-counting detector adoption, China trade and regulatory developments, tariffs, and continued product innovation.

Company facts

CEOSunny S. Sanyal
ListedJan 30, 2017
ExchangeNASDAQ
HeadquartersSalt Lake City, UT
CountryUnited States
Employees2,400
CIK0001681622
ISINUS92214X1063

Market cap$777.6M
EPS (ttm)$0.5244
P/E (ttm)35.22
ROE4.6%
P/B1.57
P/S0.8989
Dividend yieldDiv yield
Beta1.22vs XLV 0.74

Price target$14.50−21.5%Average of 7 analysts
ConsensusHold5 of 7 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 17, 2026CJS SecuritiesDowngrade
Rating: Outperform
Rating: Market Perform
Aug 11, 2026OppenheimerDowngrade
Rating: Outperform
Rating: Perform
Aug 10, 2026OppenheimerDowngrade
Rating:
Rating: Perform
Aug 10, 2026B. RileyDowngrade
Rating: Buy
Rating: Neutral
Aug 10, 2026Sidoti & Co.Downgrade
Rating: Buy
Rating: Neutral

Next report
Nov 17, 26
in 56 days
EPS estimate
$0.33
Revenue estimate
$229.8M
Fiscal quarter
Q4 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.07$0.26$0.18$0.37$0.19$0.21$0.31Pending
Estimate$0.04$0.14$0.04$0.18$0.14$0.22$0.21$0.33
Surprise+75.0%+85.7%+350.0%+105.6%+35.7%−4.5%+47.5%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$199.8M$212.9M$203.0M$228.9M$209.6M$216.0M$210.5MPending
Estimate$202.2M$209.4M$219.3M$205.8M$207.8M$216.9M$215.5M$229.8M
Surprise−1.2%+1.7%−7.4%+11.2%+0.9%−0.4%−2.3%
Estimate$0.33
ReportedDue Nov 17, 2026
Estimate$229.8M
ReportedDue Nov 17, 2026
View details

Debt to equity75.20%
Current ratio337.80%

ProfitabilityRevenueNet incomeNet margin

Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue$205.7M$199.8M$212.9M$203.0M$228.9M$209.6M$216.0M$210.5M
Net income−$50.0M−$300.0K$6.9M−$89.1M$12.2M$2.3M−$8.1M$15.7M
Net margin0.0%0.0%3.2%0.0%5.3%1.1%0.0%7.5%

GrowthOperating income

Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Operating income$10.9M$11.2M$22.1M−$80.7M$19.6M$15.4M$14.4M$22.8M
YoY growth−55.1%+166.7%+187.0%Turned loss+79.8%+37.5%−34.8%Turned profit

Balance sheet, Jul 3, 2026Cash & short-term investments $99.2M · Total debt $373.6M · Total assets $1.10B · Shareholders' equity $496.6M

Revenue
$210.5M
Operating income
$22.8M
Net income
$15.7M
View details

No dividends on record.

Institutions97.26%40.95M shares
189 holders · as of Jun 30, 2026
Insiders1.73%727.5K shares
14 holders · as of Sep 15, 2026
Strategic holders4.76%2.00M shares
1 holder · as of Aug 24, 2017
Adds to103.75%

42.10M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

These groups come from separate filings that can overlap, so they add to 103.75%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Pzena Investment Management LLCInstitution
10.32%4.34Mas of Jun 30, 2026
BlackRock, Inc.Institution
9.25%3.89Mas of Jun 30, 2026
Allspring Global Investments Holdings, LLCInstitution
5.43%2.28Mas of Jun 30, 2026
Neuberger Berman Group LLCInstitution
4.95%2.08Mas of Jun 30, 2026
QV Investors Inc.Strategic
4.76%2.00Mfiled Aug 24, 2017

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Sep 14, 2026Jay K. Kunkeldirector−8,121$18.48
Sep 11, 2026Shubham Maheshwariofficer: Chief Financial Officer−130,000$18.46
Mar 20, 2026Jay K. Kunkeldirector−4,510$11.14
Sep 19, 2025Karen L. Arankiofficer: Chief Human Resources Officer−3,174$12.34
View details

  • GE HealthCare

    Large CT and X-ray systems maker with in-house imaging components

  • Philips (ADR)

    Medical imaging OEM tied to X-ray, CT, tube, and detector competition

  • Teledyne Technologies

    Detector specialist across medical, dental, industrial, and NDT uses

  • OSI Systems

    Rapiscan security systems rival in cargo and vehicle inspection

Compare

CompanyPriceChange
Varex Imaging$18.50+0.14%$777.6M35.219.50.9+3.7%
GE HealthCare$66.33+2.34%$29.27B18.812.81.4+5.8%
Philips (ADR)$24.92+0.08%$24.34B18.712.91.2−2.8%
Teledyne Technologies$612.05+0.49%$28.23B29.424.04.4+9.8%
OSI Systems$202.39+0.99%$3.30B22.417.81.8−4.1%
Median20.615.41.6+1.5%